Crossmark

Developing anti-TDE vaccine for sensitizing cancer cells to treatment and metastasis control

Crossref DOI link: https://doi.org/10.1038/s41541-024-01035-3

Published Online: 2025-01-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Meena, Stephene S. https://orcid.org/0000-0002-5869-459X
Kosgei, Benson K. https://orcid.org/0000-0003-1206-7678
Soko, Geofrey F. https://orcid.org/0000-0002-1363-5844
Tingjun, Cheng

Chambuso, Ramadhani https://orcid.org/0000-0001-8794-604X
Mwaiselage, Julius

Han, Ray P. S. https://orcid.org/0000-0002-3551-4795
License Information

Text and Data Mining valid from 2025-01-27

Version of Record valid from 2025-01-27
More Information

Article History

Received: 13 May 2024

Accepted: 21 November 2024

First Online: 27 January 2025

Competing interests

: The authors declare no competing interests.